Ointment to Prevent Scar After Thyroidectomy

Innovo Therapeutics

Status and phase: Enrolling; Phase 2

Conditions: Scar

Treatments: Drug: INV-001

Study type: Interventional

Funder types: Industry

Identifiers

NCT05838833

INV001-01

Details and patient eligibility

About

The goal of this study is to evaluate the efficacy and Safety of INV-001 administration for the prevention of scar after thyroidectomy.

Participants will be asked to apply ointment on their scar for 12 weeks.

Full description

to evaluate the efficacy

-investigator check POSAS and VSS

Enrollment: 75 estimated patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient who got thyroidectomy due to Thyroid cancer
• has scar longer than 3 cm

Exclusion criteria

• have history about Keloid or Hypertrophic scar
• have infection on surgical site

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

75 participants in 3 patient groups, including a placebo group

Low dose

Experimental group

Description:

low dose ointment

Treatment:

Drug: INV-001

High dose

Experimental group

Description:

high dose ointment

Treatment:

Drug: INV-001

Placebo

Placebo Comparator group

Description:

same ingredient with active drug except API

Treatment:

Drug: INV-001